The Biologics & Biosimilar Congress theme will feature cutting-edge research on topics such as modern antibody-based therapeutics & engineering, immunotherapy, and protein biotherapeutics. Also, technological advancements such as antibody-drug conjugates (ADCs), success in monoclonal antibody (Mab) and antibody-derived therapeutics for chronic diseases